A PHASE 2/3 TRIAL OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

Administered By

Contributors

Start/End

  • January 5, 2018 - December 31, 2020